地佐辛临床镇痛专家共识

2020-06-30 中国临床麻醉/疼痛相关专家组(统称) 中华麻醉学杂志.2020,40(6):641-645.

地佐辛是术后镇痛常用药物,可单独用于术后轻、中度疼痛的镇痛,也可与非菌体类抗炎药(NsAID,)、强效阿片类药物等复合用于术后重度疼痛的镇痛;该药还可作为外周神经阻滞、局部浸润麻醉镇痛不足的补救用药。

中文标题:

地佐辛临床镇痛专家共识

发布日期:

2020-06-30

简要介绍:

地佐辛是术后镇痛常用药物,可单独用于术后轻、中度疼痛的镇痛,也可与非菌体类抗炎药(NsAID,)、强效阿片类药物等复合用于术后重度疼痛的镇痛;该药还可作为外周神经阻滞、局部浸润麻醉镇痛不足的补救用药。复合用药时,因为镇痛药剂量降低以及药物对各种类型阿片受体的作用不同,呼吸抑制和成瘾等副作用较少,是突出的优点。该药虽广泛应用于术后镇痛,甚至用于术中镇痛,但仍缺乏建立在循证医学基础上的评价,仍需进一步严格对照研究。

下载附件:

(因为版权问题,不支持下载)

评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1064168, encodeId=1ccb106416877, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f6f5539911, createdName=ms1000000043929022, createdTime=Tue Oct 26 19:08:34 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058988, encodeId=a66510589882a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24674119346, createdName=13bfbbb4m94暂无昵称, createdTime=Sat Oct 09 16:03:42 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006589, encodeId=c69510065892d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305562784, createdName=ms3000001459831725, createdTime=Tue Aug 10 11:24:20 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974511, encodeId=bb419e4511c0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Thu Jun 17 22:10:37 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966683, encodeId=e1669666837e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=980f5501397, createdName=ms9000000288972783, createdTime=Tue May 18 22:33:24 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
    2021-10-26 ms1000000043929022

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1064168, encodeId=1ccb106416877, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f6f5539911, createdName=ms1000000043929022, createdTime=Tue Oct 26 19:08:34 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058988, encodeId=a66510589882a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24674119346, createdName=13bfbbb4m94暂无昵称, createdTime=Sat Oct 09 16:03:42 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006589, encodeId=c69510065892d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305562784, createdName=ms3000001459831725, createdTime=Tue Aug 10 11:24:20 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974511, encodeId=bb419e4511c0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Thu Jun 17 22:10:37 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966683, encodeId=e1669666837e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=980f5501397, createdName=ms9000000288972783, createdTime=Tue May 18 22:33:24 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
    2021-10-09 13bfbbb4m94暂无昵称

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1064168, encodeId=1ccb106416877, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f6f5539911, createdName=ms1000000043929022, createdTime=Tue Oct 26 19:08:34 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058988, encodeId=a66510589882a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24674119346, createdName=13bfbbb4m94暂无昵称, createdTime=Sat Oct 09 16:03:42 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006589, encodeId=c69510065892d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305562784, createdName=ms3000001459831725, createdTime=Tue Aug 10 11:24:20 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974511, encodeId=bb419e4511c0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Thu Jun 17 22:10:37 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966683, encodeId=e1669666837e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=980f5501397, createdName=ms9000000288972783, createdTime=Tue May 18 22:33:24 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
    2021-08-10 ms3000001459831725

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1064168, encodeId=1ccb106416877, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f6f5539911, createdName=ms1000000043929022, createdTime=Tue Oct 26 19:08:34 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058988, encodeId=a66510589882a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24674119346, createdName=13bfbbb4m94暂无昵称, createdTime=Sat Oct 09 16:03:42 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006589, encodeId=c69510065892d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305562784, createdName=ms3000001459831725, createdTime=Tue Aug 10 11:24:20 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974511, encodeId=bb419e4511c0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Thu Jun 17 22:10:37 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966683, encodeId=e1669666837e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=980f5501397, createdName=ms9000000288972783, createdTime=Tue May 18 22:33:24 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
    2021-06-17 麻无赦

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1064168, encodeId=1ccb106416877, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f6f5539911, createdName=ms1000000043929022, createdTime=Tue Oct 26 19:08:34 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058988, encodeId=a66510589882a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24674119346, createdName=13bfbbb4m94暂无昵称, createdTime=Sat Oct 09 16:03:42 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006589, encodeId=c69510065892d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3305562784, createdName=ms3000001459831725, createdTime=Tue Aug 10 11:24:20 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974511, encodeId=bb419e4511c0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Thu Jun 17 22:10:37 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966683, encodeId=e1669666837e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=980f5501397, createdName=ms9000000288972783, createdTime=Tue May 18 22:33:24 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
    2021-05-18 ms9000000288972783

    学习了

    0

拓展阅读

中国心脏重症镇静镇痛专家共识

国内急诊/重症相关专家小组(统称) · 2017-03-14

2016 ACOG实践简报:产科镇痛和麻醉(No.177)

美国妇产科医师学会(ACOG,American College of Obstetricians and Gynecologists) · 2017-04-01

2017 ASER/POQI联合共识声明:优化镇痛加速结直肠癌手术康复(一)

美国促进恢复学会(ASER,American Society for Enhanced Recovery) · 2017-04-13

2017 ASER/POQI联合共识声明:优化镇痛加速结直肠癌手术康复(二)

美国促进恢复学会(ASER,American Society for Enhanced Recovery) · 2017-04-13

2018 循证临床指南:接受辅助通气和气管插管的新生儿的镇静和镇痛

国外儿科相关医学专家组(统称) · 2018-10-05